COVID-19 Detection Kits Market, by Product Type (RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes), by Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Sputum, and Others), by End User (Hospitals, Diagnostic Centers, and Others),

COVID-19 Detection Kits Market, by Product Type (RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes), by Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Sputum, and Others), by End User (Hospitals, Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

COVID-19 detection kits can identify the SARS-CoV-2 or coronavirus through two methods. The first method is the RT-PCR method in which the presence of the virus itself is detected and the second is an immunoassay test which detects antibodies produced in response to the infection. In order to prevent further spread of the virus, governments and regulatory authorities all over the world are focusing on conducting maximum number of COVID-19 detection tests which has led to a high demand for COVID-19 detection kits globally. For instance, on April 04, 2022, the Department of Health and Social Care, UK, reported that National Health Service has conducted around 200,000 tests so far and has also scaled up the testing capacity from 5,000 to 10,000 tests per day in the U.K. According to the same source, the National Health Service is planning to increase the capacity to nearly 25,000 swab tests per day by the end of April in the U.K. Hence, the increasing demand for COVID-19 detection is expected to boost the market growth during the forecast period.
Market Dynamics
The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players to increase the production of COVID-19 tests is expected to propel the market growth during the forecast period. For instance, on April 14, 2022, Co-Diagnostics, Inc., a molecular diagnostics company, collaborated with Promega Corporation, a provider of molecular diagnostic components, to amplify the production of Logix Smart COVID-19 tests. This collaboration will allow Co-Diagnostics, Inc. to meet the demand for COVID-19 tests and strengthen its presence in the U.S.
Similarly, on April 29, 2022, Centene Corporation collaborated with Quest Diagnostics, provider of diagnostic information services to increase availability of real-time reverse transcription polymerase chain reaction (rRT-PCR) COVID-19 testing in the U.S. Through this collaboration, Centene will distribute around 25,000 Quest COVID-19 test kits every week to Federally Qualified Health Centers (FQHCs) in ten states or districts across the U.S.
Key features of the study:
This report provides in-depth analysis of the global COVID-19 detection kits market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global COVID-19 detection kits market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are Co-Diagnostics, Inc F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific, Abbott Laboratories, BGI, Cepheid Inc, BioFire Diagnostics, GenMark Diagnostics, Qiagen, Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, INC., Shenzhen Bioeasy Biotechnology Co., Ltd., and Seegene Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, Specimen Type up-gradation, market expansion, and marketing tactics
The global COVID-19 detection kits market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global COVID-19 detection kits market
Detailed Segmentation:
Global COVID-19 detection kits Market, By Product Type:
RT-PCR Assay Kits
Immunoassay Test Strips/Cassettes
Global COVID-19 detection kits Market, By Specimen Type:
Nasopharyngeal swab
Oropharyngeal swab
Nasal swab
Sputum
Others
Global COVID-19 detection kits Market, By End User:
Hospitals
Diagnostic centers
Others
Global COVID-19 detection kits Market, By Region:
North America
By Product Type
RT-PCR Assay Kits
Immunoassay Test Strips/Cassettes
By Specimen Type:
Nasopharyngeal swab
Oropharyngeal swab
Nasal swab
Sputum
Others
By End User:
Hospitals
Diagnostic centers
Others
By Country:
U.S.
Canada
Latin America
By Product Type
RT-PCR Assay Kits
Immunoassay Test Strips/Cassettes
By Specimen Type:
Nasopharyngeal swab
Oropharyngeal swab
Nasal swab
Sputum
Others
By End User:
Hospitals
Diagnostic centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type
RT-PCR Assay Kits
Immunoassay Test Strips/Cassettes
By Specimen Type:
Nasopharyngeal swab
Oropharyngeal swab
Nasal swab
Sputum
Others
By End User:
Hospitals
Diagnostic centers
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
RT-PCR Assay Kits
Immunoassay Test Strips/Cassettes
By Specimen Type:
Nasopharyngeal swab
Oropharyngeal swab
Nasal swab
Sputum
Others
By End User:
Hospitals
Diagnostic centers
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type
RT-PCR Assay Kits
Immunoassay Test Strips/Cassettes
By Specimen Type:
Nasopharyngeal swab
Oropharyngeal swab
Nasal swab
Sputum
Others
By End User:
Hospitals
Diagnostic centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type
RT-PCR Assay Kits
Immunoassay Test Strips/Cassettes
By Specimen Type:
Nasopharyngeal swab
Oropharyngeal swab
Nasal swab
Sputum
Others
By End User:
Hospitals
Diagnostic centers
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Co-Diagnostics, Inc*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
F. Hoffmann-La Roche AG
Siemens Healthineers AG
Thermo Fisher Scientific
Abbott Laboratories
BGI
Cepheid Inc
BioFire Diagnostics
GenMark Diagnostics
Qiagen
Quidel Corporation
Randox Laboratories Ltd.
SD Biosensor, INC.
Shenzhen Bioeasy Biotechnology Co., Ltd.
Seegene Inc.
“*” marked represents similar segmentation in other categories in the respective section.